HAL (France)open access
Defining the Roles of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Management of Chronic Kidney Disease in Adults with Type 2 Diabetes With or Without Overweight/Obesity: An International Delphi Consensus
0, Chronic kidney disease, Sodium-glucose co-transporter 2 inhibitor, Glucagon-like peptide-1 receptor agonist
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 280369
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.